
Providing education interventions to pharmacists can affect the nature of conversations about pneumococcal vaccination in older adults, according to a new study published in the Journal of the American Pharmacists Association.1
Although the Public Health Agency of Canada has a target vaccination rate of 80%, only 58% of Canadiens aged 65 years and older have been vaccinated for pneumococcal pneumonia.
Pharmacist education can positively impact patient counseling around vaccinations in older adults. | Image credit: C. Davids/peopleimages.com – stock.adobe.com

The researchers wanted to discover the reasons behind patients’ reluctance to get vaccinated. They sought to explore the conversations about the pneumococcal vaccine between pharmacists and patients.
Investigators randomly selected pharmacies to receive education packages, which were designed to increase knowledge, skills, and abilities for promoting pneumococcal vaccination. The educational toolkit included patient screening tips, a decision tree for patient eligibility, consent forms, a poster on vaccine safety, vaccine comparison table, frequently asked questions, and several documentation templates. Pharmacists watched a 1-hour video that gave them an overview of the study and all educational materials.
During the control stage, pharmacists provided usual care. The intervention stage occurred after the pharmacists received the educational packages. The researchers used weekly scorecards to assess pharmacist-patient conversations, including the number of conversations, the length of each conversation, and reasons for vaccine refusal. They used chi-squared tests to compare the time taken for conversations and patient-reported reasons for refusing the vaccine during the control and intervention stages.
The study included 656 pharmacist-patient conversations from 13 pharmacies across Alberta, Canada. Of these conversations, 271 occurred during the control stage, and 385 occurred during the intervention stage.
READ MORE: At Higher Risk, Vaccine Efficacy, Uptake Are Crucial for Older Adult Populations
After receiving the educational package, the duration of pharmacist-patient conversations that resulted in a vaccine decreased—65% of conversations during the control phase took less than 20 minutes compared with 88% during the intervention phase. Conversations that resulted in vaccine refusal remained about the same length between the control and interventional stages, with 70% and 76% lasting for less than 5 minutes, respectively.
During both phases of the study, the most common reason for vaccine refusal was “needing more time to think about the vaccine”—this accounted for 31% of all refusals during the control stage and 36% during the intervention stage. However, fewer patients cited “lack of time to receive it today” and “perceived lack of benefit” as the reason for refusing the vaccine during the intervention phase. More patients refused the vaccine due to “cost barriers” during the intervention stage compared with the control, and more patients “wanted to consult with family members.”
Patients’ reasons for refusal that did not significantly change between the control and intervention phases included “fear of adverse events,” “lack of perceived susceptibility,” and “wanting to consult with their family doctor.”
The researchers noted that their scorecards did not allow them to track pneumococcal vaccinations that occurred elsewhere or at a different time. Thus, they could not report accurately on how vaccination rates changed after pharmacist-patient conversations.
In a future study, the researchers will assess the most useful components of the educational toolkit, allowing them to refine the program.
READ MORE: Immunization Resource Center
Reference
1. Ramrattan D, Nagy D, Eurich D, Hughes C, Lau D, Simpson S. Changing the conversation: Empowering community pharmacists to address pneumococcal vaccine hesitancy. J Am Pharm Assoc. 2024;64:e102202. doi:10.1016/j.japh.2024.102202
Pneumococcal Vaccination
Here is the short version of Pneumococcal Vaccination, including what to check first and what to ignore.
What should beginners know about Pneumococcal Vaccination?
Start with the basics covered above, apply one change at a time, and note what happens. That way you can tell which step actually made the difference instead of guessing.
How long does Pneumococcal Vaccination take to show results?
It depends on your starting point. Most readers see a clear difference after four to six weeks of consistent work, and sooner when they track results weekly.
If Pneumococcal Vaccination feels overwhelming, start with the smallest step that produces a visible result.





Related reading
- Suborna Ahmed Receives UBC Open Education Resources (OER)
- Supporting Early Learning: How to Choose The Best Education
For background context, see U.S. Department of Education.
Mistakes that cost time and money
The most common mistake with Pneumococcal Vaccination is treating the first option you find as the only option. Comparison is not busywork: differences in scope, support, and timing often matter more than the headline number.
The second mistake is ignoring the follow-up. Whatever you choose, plan how you will check that it worked. A quick review after two weeks catches problems while they are still cheap to fix, and it turns Pneumococcal Vaccination from a one-time decision into something you can improve.
What to check before you start
Before committing time or money to Pneumococcal Vaccination, it helps to know what a good outcome looks like. Write down the result you actually need, the budget you can live with, and the deadline you are working against. Those three answers rule out most of the options that look attractive but do not fit your situation.
Next, look at the details that are easy to miss: what is included, what costs extra, and what happens when something goes wrong. Ask directly about timelines and follow-up. A clear answer is usually a better sign than a low price, because Pneumococcal Vaccination is rarely a one-off purchase of attention.
A simple step-by-step approach
Start with the basics of Pneumococcal Vaccination and keep the first step small enough to finish in one sitting. Gather the information you need, compare two or three realistic options, and note the trade-offs in plain language rather than marketing terms.
Then test the decision on a small scale before you scale it up. This is the part most people skip, and it is the reason Pneumococcal Vaccination sometimes feels harder than it should. A short trial tells you more than another hour of reading, and it usually surfaces the one constraint that matters in your case.






:max_bytes(150000):strip_icc():focal(688x376:690x378)/upset-bride-groom-082224-4ca893239da740cc951fb038412fefb0.jpg)



